PHARMA
Researchers Commence Clinical Trial Of Streptococcus A Vaccine
Researchers in Australia have begun human trials of a vaccine for Streptococcus A, the bacterium that causes rheumatic fever.
Flu Vaccine Candidate May Have Broad Spectrum Efficacy
Researchers have designed a new drug to safeguard against epidemic and pandemic influenza virus strains.
Pfizer To Conduct NSCLC Drug Trial In Asia
Pfizer Inc. will conduct a clinical trial of its crizotinib drug, marketed under the trademark Xalkori®, in four Asian countries.
Adaptive Licensing To Speed Up Drug Approvals In Singapore
Singapore's health regulatory agency is implementing a new drug development regulatory model to accelerate the translation of drugs into the clinic.
Vabiotech Licenses Japanese Encephalitis Technology From Inviragen
Vietnam's VABIOTECH has acquired rights to Inviragen's proprietary Japanese encephalitis technology to produce a cell-derived vaccine.
MRC Technology, Chinese Acad of Sciences To Find New Drug Targets
MRC Technology and the Shanghai Institute of Biochemistry and Cell Biology have agreed to collaborate on drug discovery.
AstraZeneca, LegoChem Biosciences To Co-Develop Novel Antibiotics
AstraZeneca has licensed an antibiotic drug candidate from South Korea's LegoChem Biosciences to treat drug-resistant bacterial infections.
Astellas Pharma Releases Phase II Data For Leukemia Drug
Approximately 50 percent of FLT3-ITD positive AML patients achieved complete remission with Astellas Pharma's new investigational drug, according to Phase II data results.
Ranbaxy Halts Generic Lipitor Production After Glass Contamination Scare
A possible contamination with very small glass particles has sparked the voluntary recall of Ranbaxy Pharmaceutical’s atorvastatin tablets.
